March 16, 2023

HealthTree Foundation and Adaptive joined forces to understand the awareness, knowledge, and perceptions of MRD testing among patients with multiple myeloma.

February 22, 2023

How do you make treatment decisions at myeloma relapse? Share your experience in our decision-making survey.

February 21, 2023

HealthTree developed a study that looked at how the number of medications used to treat myeloma affected the genetic risk of patients. 

February 01, 2023

A HealthTree Research study shows adding another drug to a myeloma regimen did not increase the presence or severity of side effects.

August 22, 2022

Survey results from a study on nutrition perceptions and practices in myeloma patients.

July 26, 2022

A HealthTree Research study about genetic and imaging testing on myeloma patients.

June 14, 2022

The flood of bispecific antibodies is coming, with new data emerging from the recent EHA meeting

June 12, 2022

How important is your free light chain ratio when watching progression from smoldering myeloma to active myeloma? Dr. Theresia Akhlaghi shares new insights.

June 10, 2022

The European Hematology Association (EHA) conference has begun in Vienna, teaching us more about immunotherapy in myeloma

May 30, 2022

Understanding the psychosocial distress and unmet needs among myeloma patients during the pandemic.